Skip to main content

NOVO-B · Novo Nordisk A S · Financials

255.2500 DKK +5.3500 (+2.14%) At close · Oct 9

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Browse captured authority reports and their original financial labels

Revenue
309.06B +6.4%
FY2025 Revenue FY2015–FY2025
Net Income
102.43B +1.4%
FY2025 Net Income FY2015–FY2025
Gross Margin
80.98% -3.7pp
FY2025 Gross Margin FY2015–FY2025
Operating Margin
41.3% -2.9pp
FY2025 Operating Margin FY2015–FY2025
Diluted EPS
23.03 +1.8%
FY2025 Diluted EPS FY2015–FY2025
Operating Cash Flow
119.1B -1.5%
FY2025 Operating Cash Flow FY2015–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015
DKK 309.06B 290.4B 232.26B 176.95B 140.8B 126.95B 122.02B 111.83B 111.7B 111.78B 107.93B
DKK 58.79B 44.52B 35.77B 28.45B 23.66B 20.93B 20.09B 17.62B 17.63B 17.18B 16.19B
DKK 250.28B 245.88B 196.5B 148.51B 117.14B 106.01B 101.93B 94.21B 94.06B 94.6B 91.74B
DKK 52.04B 48.06B 32.44B 24.05B 17.77B 15.46B 14.22B 14.81B 14.01B 14.56B 13.61B
DKK 5.97B 5.28B 4.86B 4.47B 4.05B 3.96B 4.01B 3.92B 3.78B 3.96B 3.86B
DKK 14.67B 8.55B 7.29B 6.55B — — — — — — —
DKK 127.66B 128.34B 102.57B 74.81B 58.64B 54.13B 52.48B 47.25B 48.97B 48.43B 49.44B
DKK 6.78B 7.35B 845M 5.99B 2.45B 2.62B 4B 1.76B 1.53B 726M 6.05B
DKK 130.54B 127.19B 104.67B 69.06B 59.08B 53.13B 48.55B 47.62B 48.68B 47.8B 43.48B
DKK 28.11B 26.2B 20.99B 13.54B 11.32B 10.99B 9.6B 8.99B 10.55B 9.87B 8.62B
DKK 102.43B 100.99B 83.68B 55.53B 47.76B 42.14B 38.95B 38.63B 38.13B 37.93B 34.86B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2015–FY2025: 191.88B in buybacks, 288.65B in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Bonds issued 2025-12-31 DKK 121,074,000,000 20-F filed 2026-02-04
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current bonds issued, including current portion of noncurrent bonds
DKK 9,701,000,000
Noncurrent bonds issued
DKK 111,373,000,000
Borrowings 2025-12-31 DKK 130,958,000,000 20-F filed 2026-02-04
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current portion of long-term borrowings
DKK 12,017,000,000
Noncurrent long-term borrowings
DKK 118,941,000,000
Short-term borrowings
DKK 12,017,000,000
Borrowings 2025-12-31 EUR 10,000,000,000 20-F filed 2026-02-04
Lease liabilities 2025-12-31 DKK 8,572,000,000 20-F filed 2026-02-04
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current lease liabilities
DKK 1,336,000,000
Noncurrent lease liabilities
DKK 7,236,000,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.